4GRG
Crystal structure of IgE complexed with E2_79, an anti-IgE inhibitor
4GRG の概要
エントリーDOI | 10.2210/pdb4grg/pdb |
分子名称 | ANTI-IGE INHIBITOR E2_79, Ig epsilon chain C region (2 entities in total) |
機能のキーワード | ig-fold, immunity, high/low affinity receptor, immune system-inhibitor complex, immune system/inhibitor |
由来する生物種 | Escherichia coli 詳細 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 80570.30 |
構造登録者 | |
主引用文献 | Kim, B.,Eggel, A.,Tarchevskaya, S.S.,Vogel, M.,Prinz, H.,Jardetzky, T.S. Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor. Nature, 491:613-617, 2012 Cited by PubMed Abstract: IgE antibodies bind the high-affinity IgE Fc receptor (FcεRI), found primarily on mast cells and basophils, and trigger inflammatory cascades of the allergic response. Inhibitors of IgE-FcεRI binding have been identified and an anti-IgE therapeutic antibody (omalizumab) is used to treat severe allergic asthma. However, preformed IgE-FcεRI complexes that prime cells before allergen exposure dissociate extremely slowly and cannot be disrupted by strictly competitive inhibitors. IgE-Fc conformational flexibility indicated that inhibition could be mediated by allosteric or other non-classical mechanisms. Here we demonstrate that an engineered protein inhibitor, DARPin E2_79 (refs 9, 10, 11), acts through a non-classical inhibition mechanism, not only blocking IgE-FcεRI interactions, but actively stimulating the dissociation of preformed ligand-receptor complexes. The structure of the E2_79-IgE-Fc(3-4) complex predicts the presence of two non-equivalent E2_79 sites in the asymmetric IgE-FcεRI complex, with site 1 distant from the receptor and site 2 exhibiting partial steric overlap. Although the structure is indicative of an allosteric inhibition mechanism, mutational studies and quantitative kinetic modelling indicate that E2_79 acts through a facilitated dissociation mechanism at site 2 alone. These results demonstrate that high-affinity IgE-FcεRI complexes can be actively dissociated to block the allergic response and suggest that protein-protein complexes may be more generally amenable to active disruption by macromolecular inhibitors. PubMed: 23103871DOI: 10.1038/nature11546 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (4.24 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード